Perfil
Dr. Dolores J.
Schendel is a Chief Scientific Officer at MediGene AG and a Chief Executive Officer at Medigene, Inc. Dr. Schendel was previously employed as a Managing Director by Medigene Immunotherapies GmbH, a Member-Scientific Review Board by Deutsche Forschungsgemeinschaft, a Member-Scientific Review Board by European Research Council, a Member-Scientific Review Board by German Cancer Aid, and a Professor by Ludwig-Maximilians-Universität München.
She also served on the board at Institute of Molecular Immunology.
She received her doctorate degree from the University of Wisconsin.
Cargos activos de Dolores Schendel
| Empresas | Cargo | Inicio |
|---|---|---|
| MEDIGENE AG | Director Técnico/Científico/I+D | 01/05/2014 |
MediGene, Inc.
MediGene, Inc. Pharmaceuticals: MajorHealth Technology Develops herpes simplex virus technologies for the treatment of tumors and for gene delivery | Director Ejecutivo | - |
Antiguos cargos conocidos de Dolores Schendel.
| Empresas | Cargo | Fin |
|---|---|---|
Institute of Molecular Immunology | Director/Miembro de la Junta | 01/01/2013 |
European Research Council
European Research Council Investment Trusts/Mutual FundsMiscellaneous Provides funding initiative designed to support the scientists, engineers, and scholars | Corporate Officer/Principal | - |
German Cancer Aid | Corporate Officer/Principal | - |
Deutsche Forschungsgemeinschaft
Deutsche Forschungsgemeinschaft Other Consumer ServicesConsumer Services Functions as a College/University | Corporate Officer/Principal | - |
Medigene Immunotherapies GmbH
Medigene Immunotherapies GmbH Pharmaceuticals: MajorHealth Technology Develops immunotherapy to treat cancer | Director Ejecutivo | - |
Formación de Dolores Schendel.
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
| Empresas privadas | 9 |
|---|---|
MediGene AG
MediGene AG BiotechnologyHealth Technology Engages in the clinical research and development of novel drugs against cancer & autoimmune diseases with focus on personalized immunotherapies | Health Technology |
MediGene, Inc.
MediGene, Inc. Pharmaceuticals: MajorHealth Technology Develops herpes simplex virus technologies for the treatment of tumors and for gene delivery | Health Technology |
University of Wisconsin
University of Wisconsin Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Ludwig-Maximilians-Universität München
Ludwig-Maximilians-Universität München Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
European Research Council
European Research Council Investment Trusts/Mutual FundsMiscellaneous Provides funding initiative designed to support the scientists, engineers, and scholars | Miscellaneous |
Deutsche Forschungsgemeinschaft
Deutsche Forschungsgemeinschaft Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Institute of Molecular Immunology | |
Medigene Immunotherapies GmbH
Medigene Immunotherapies GmbH Pharmaceuticals: MajorHealth Technology Develops immunotherapy to treat cancer | Health Technology |
German Cancer Aid |
- Bolsa de valores
- Insiders
- Dolores Schendel
















